What is BTS Research?
BTS Research, a San Diego-based Contract Research Organization (CRO) founded in 2001, specializes in providing comprehensive preclinical services. Their expertise spans both in vitro and in vivo biological studies, crucial for drug discovery, toxicology assessments, and pharmacology. The company offers extensive support throughout the Investigational New Drug (IND) process, serving a diverse clientele that includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and academic research institutions. BTS Research is committed to maintaining high standards of scientific quality and regulatory compliance, leveraging state-of-the-art laboratory facilities and vivarium to advance drug development pipelines for a variety of disease models and custom research needs.
How much funding has BTS Research raised?
BTS Research has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for BTS Research?
With its large-scale late-stage funding context, BTS Research is poised for significant expansion and enhancement of its preclinical service offerings. This strategic investment is likely to fuel advancements in their technological capabilities, potentially broadening their service portfolio or increasing capacity to meet growing demand. The company's focus on regulatory compliance and scientific rigor suggests that future growth will be directed towards solidifying its reputation as a premier CRO, enabling more efficient and effective progression of client drug development programs from discovery through to IND submission.
See full BTS Research company page
